Currency in
| Earnings estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 0 | 0 | 1 | 0 |
| Avg. Estimate | 0 | 0 | -11.7 | 0 |
| Low estimate | 0 | 0 | -11.7 | 0 |
| High estimate | 0 | 0 | -11.7 | 0 |
| Year ago EPS | N/A | N/A | -41 | -11.7 |
| Revenue estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 0 | 0 | 1 | 0 |
| Avg. Estimate | N/A | N/A | 9M | N/A |
| Low estimate | N/A | N/A | 9M | N/A |
| High estimate | N/A | N/A | 9M | N/A |
| Year ago sales | N/A | N/A | 6.98M | 9M |
| Sales growth (year/est) | N/A | N/A | 29.00% | N/A |
| Earnings history | Invalid Date | Invalid Date | Invalid Date | Invalid Date |
|---|
| Est. EPS | N/A | N/A | N/A | N/A |
| Actual EPS | N/A | N/A | N/A | N/A |
| Difference | N/A | N/A | N/A | N/A |
| Surprise % | N/A | N/A | N/A | N/A |
| EPS trend | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| Current estimate | 0 | 0 | -11.7 | 0 |
| 7 days ago | 0 | 0 | -11.7 | 0 |
| 30 days ago | 0 | 0 | -11.7 | 0 |
| 60 days ago | 0 | 0 | 0 | 0 |
| 90 days ago | 0 | 0 | 0 | 0 |
| EPS revisions | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| Up last 7 days | N/A | N/A | N/A | N/A |
| Up last 30 days | N/A | N/A | N/A | N/A |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | N/A | N/A | N/A | N/A |
| Growth estimates | BIOM.L | Industry | Sector(s) | S&P 500 |
|---|
| Current qtr. | N/A | N/A | N/A | N/A |
| Next qtr. | N/A | N/A | N/A | N/A |
| Current year | 71.50% | N/A | N/A | N/A |
| Next year | N/A | N/A | N/A | N/A |
| Next 5 years (per annum) | N/A | N/A | N/A | N/A |
| Past 5 years (per annum) | N/A | N/A | N/A | N/A |
